Amedisys Inc.

11/13/2024 | Press release | Distributed by Public on 11/13/2024 16:08

Initial Statement of Beneficial Ownership - Form 3

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Griffin Jennifer G
2. Date of Event Requiring Statement (Month/Day/Year)
2024-11-04 		3. Issuer Name and Ticker or Trading Symbol
AMEDISYS INC [AMED]
(Last) (First) (Middle)
3854 AMERICAN WAY, SUITE A
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
Chief Legal Officer /
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
BATON ROUGE LA 70816
6. Individual or Join/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security 2. Amount of Securities Beneficially Owned 3. Ownership Form: Direct (D) or Indirect (I) 4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Date Exercisable and Expiration Date 3. Title and Amount of Securities Underlying Derivative Security 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 6. Nature of Indirect Beneficial Ownership
Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Griffin Jennifer G
3854 AMERICAN WAY, SUITE A

BATON ROUGE, LA70816

Chief Legal Officer

Signatures

Jennifer Guckert Griffin 2024-11-13
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 551 time-based restricted stock units ("RSUs") that vest on February 16, 2025; 552 time-based RSUs that vest on each of February 16, 2026, 2027 and 2028; 3,655 time-based RSUs that vest on June 26, 2025; 3,654 time-based RSUs that vest on June 26, 2026; 647 time-based RSUs that vest on each of May 3, 2025 and 2026; 648 time-based RSUs that vest on May 3, 2027; 349 time-based RSUs that vest on each of June 1, 2025 and 2026; and 50 time-based RSUs that vest on July 25, 2025, assuming in each case that the Reporting Person remains continuously employed by the Issuer on each such vesting date. Also includes 294 shares held in an employee stock purchase plan account.
(2) The information in this report is based on a plan statement dated as of September 30, 2024.
(3) The stock options are subject to time-based vesting conditions. 372 stock options are fully vested and immediately exercisable, and 124 stock options will vest on July 25, 2025, provided that the Reporting Person remains continuously employed by the Issuer on such date.
(4) All 563 stock options are fully vested and immediately exercisable.
(5) All 640 stock options are fully vested and immediately exercisable.
(6) All 327 stock options are fully vested and immediately exercisable.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.